Amyris Biotechnologies creates renewable products, focusing on fuels and chemicals. The company plans to enter the market by 2011.
The company is developing renewable fuels that reduce lifecycle (GHG) emissions 80%. The fuel source is special in that it is compatible with current gasoline engines, and can be distributed with existing petroleum infrastructure.
Amyris is also developing semi-synthetic artemisinin, a key ingredient in first-line malaria treatments, in hopes of creating a complementary source of non-seasonal, high-quality, affordable artemisinin. This source would supplement the current botanical supply, offering millions of people infected with malaria the chance to gain consistent and reliable access to lower-cost, life-saving Artemisinin-based Combination Therapies (ACTs).
Lastly, Amyris produces environmentally friendly chemicals for a variety of consumer products and industrial applications currently dependent on petrochemical components.
Current Team (17)Update
President, Research & Development
Chairman, Director and Lead Independent Director
Mar 1, 2011
General Counsel & Corporate Secretary
Oct 1, 2010
Vice President, Global Manufacturing & Process Development
Past Team (4)Update
Funding Rounds (10) - $417MUpdate
$83.7M / Post Ipo Equity
Feb 27, 2012
$7M / Post Ipo Equity
Oct 28, 2011
$13.8M / Post Ipo Equity
Oct 12, 2010
$133.2M / Series D
Jul 2, 2010Investors:
$24.3M / Grant
Dec 1, 2009
$41.8M / Series C
Oct 1, 2009Investors:
$21M / Series B
Aug 14, 2008Investors:
$2.4M / Unknown
Feb 7, 2008
$70M / Series B
Sep 19, 2007Investors:
$20M / Series A
Oct 12, 2006Investors:
Board Members and Advisors (6)Update
Director and Chair of the Audit Committee
Director and Chair of the Leadership Development and Compensation Committee
Director and Chair of the Nominating and Governance Committee
board of directors
Board Member & Directors
Asia-based investment firm
Venture Capital Firm
VNN, the Venture Capital and Private Equity arm of the Votorantim Group, invests in businesses...
TPG Growth is the investment platform for the early stage and growth investments of TPG, a...
Khosla Ventures is a venture capital firm started in 2004 by Vinod Khosla, Co-Founder of Sun...
The firm invests in a variety of IT, energy, and life sciences companies.
5885 Hollis Street,
Emeryville, CA 94608